Akorn said it will continue to operate as usual throughout the duration of the Chapter 11 and sale process, including meeting its contractual obligations and making payments to vendors.
Clobetasol propionate shampoo 0.05% had an estimated market value of $28 million, and Doxycycline Hyclate tablets 100 mg had a market value of roughly $53 million, for the 12 months ended December 2019.